Article Details
Retrieved on: 2024-10-12 16:57:55
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Vanguard Group Inc. now owns 13,670,944 shares of the biopharmaceutical company's stock worth $233,500,000 after purchasing an additional 199,770 ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here